The Hurvis Group

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Nov 16, 2023	On Target Laboratories	$30.0M Series C	—	3B Future Health Fund, Elevate Ventures, Gwen Watanabe, Johnson & Johnson Innovation, Nacho Abia, Pension Fund of the Christian Church
Mar 24, 2021	On Target Laboratories	$21.0M Series B Extension	—	3B Future Health Fund, Elevate Ventures, H.I.G. Capital, Johnson & Johnson Innovation

Total Raised

N/A

Valuation

N/A